Skip to main content
. 2016 Aug 24;7(39):64043–64052. doi: 10.18632/oncotarget.11581

Table 3. Overall survival (OS) and progression-free survival (PFS) rates.

OS rate (%) PFS rate (%)
1-year 3-year 5-year P 1-year 3-year 5-year P
Region Group 1 83.5 58.1 42.2 0.554 73.6 46.5 31.6 0.614
Group 2 79.7 49.5 40.4 71.4 32.4 30.6

Group 1: decreased methylation level of tumor relative to the cut-off (70.3%)

Group 2: elevated methylation level of tumor relative to the cut-off (70.3%)